Celgene European Investment Co LLC's Net Worth
-$133 Million
Who is Celgene European Investment Co LLC?
Celgene European Investment Co LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., and Epizyme, Inc..
SEC CIK
Celgene European Investment Co LLC's CIK is 0001577650
Past Insider Trading and Trends
2013 was Celgene European Investment Co LLC's most active year for acquiring shares with 5 total transactions. Celgene European Investment Co LLC's most active month to acquire stocks was the month of June. 2013 was Celgene European Investment Co LLC's most active year for disposing of shares, totalling 3 transactions. Celgene European Investment Co LLC's most active month to dispose stocks was the month of June. 2018 saw Celgene European Investment Co LLC paying a total of $114,054,636.00 for 1,702,308 shares, this is the most they've acquired in one year. In 2013 Celgene European Investment Co LLC cashed out on 20,833,969 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $23.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.33% | 403.23K |
$31.00 | $12,499,975.00 | 1.78M |
Nov 12
| |||
Form 4/A
| +162.61% | 851.15K |
$67.00 | $57,027,318.00 | 1.37M |
Jan 23
| |||
Form 4
| +162.61% | 851.15K |
$67.00 | $57,027,318.00 | 1.37M |
Jan 23
| |||
Form 4
| +50.71% | 624.58K |
$49.50 | $30,916,462.50 | 1.86M |
Apr 24
| |||
Form 4
| +22.79% | 228.65K |
$110.75 | $25,322,433.75 | 1.23M |
Dec 16
| |||
Form 4
| +41.62% | 294.8K |
$44.00 | $12,971,200.00 | 1M |
Apr 29
| |||
Form 4
|
∞
| 4.72M |
$18.00 | $12,749,994.00 | 4.72M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.20% | 340K |
$29.25 | $9,945,000.00 | 3.67M |
Feb 10
| |||
Form 4
|
∞
| 3.33M |
$15.00 |
—
| 3.33M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||